Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Cocaine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000315
NIDA-09482-1
R01-09482-1

Details and patient eligibility

About

The purpose of this study is to determine the density of DA transporters during prolonged cocaine abuse and during withdrawal from cocaine use. This aim will test the hypothesis that DA transporters are altered by cocaine abuse and reestablished during withdrawal.

Sex

Male

Ages

21 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems